reports
Pyramisa Hotels: 1 director
A director at Pyramisa Hotels sold/bought 35,105 shares at 0.000EGP and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary a...
Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary Spangenberg brings significant IP monetization experience and the potential to unlock additional value for Spectral AI shareholders DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Erich Spangenberg has been appointed as the Chief Executive Officer of its ...
SEALSQ’s IoMT Solutions Provide the Highest Security Standards in Medi...
SEALSQ’s IoMT Solutions Provide the Highest Security Standards in Medical and Healthcare, Essential for Safeguarding Sensitive Patient Data Geneva, Switzerland, April 24, 2024 (GLOBE NEWSWIRE) -- SEALSQ’s semiconductor technology provides secure, reliable, and intuitive functionality for a wide array of medical applications. SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced its technology strategy and solutions for IoMT security for medica...
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with...
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center -- Helius Medical and Shepherd Center partner on a study that aims at rehabilitating walking mobility in people recovering from stroke ---- Shepherd Center, a top neurorehabilitation hospital, is the third site in Helius’ U.S. registrational program for Portable Neuromodulation Stimulator (PoNS®) in stroke ---- The single-arm study will evaluate PoNS in treating gait and balance deficits in chronic stroke survivors ---- Regulatory submission seeking marketing authorization for stroke expe...
Moody's Ratings assigns definitive rating to Class A notes issued by B...
Moody's Ratings (Moody's) announced that it has assigned the following definitive rating to notes issued by Bain Capital Euro CLO 2024-1 Designated Activity Company (the "Issuer"): ....EUR 248,000,000 Class A Senior Secured Floating Rate Notes due 2038, Assigned Aaa (sf) RATINGS RATIONALE The ...
Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporat...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation 24-Apr-2024 / 13:58 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a tr...
Form 8.3 - The Vanguard Group, Inc.: Hipgnosis Songs Fund Limited
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Hipgnosis Songs Fund Limited 24-Apr-2024 / 13:56 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the...
Form 8.3 - The Vanguard Group, Inc.: International Paper Company
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: International Paper Company 24-Apr-2024 / 13:57 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the ...
- Si Yong Ng
Mahle - New Issue Assessment - Lucror Analytics
Mahle has launched a EUR 400 mm 7Y unsecured notes offering. Proceeds from the proposed offering will be used to repay six tranches of the issuer's promissory notes, fully repay its EUR 30 mn private-placement corporate bond, add EUR 63 mn of cash to the balance sheet, and pay transaction fees and expenses. We recommend investors participate in the offering at current price talk in the high 6% range. . To request full and unrestricted access to Lucror’s research and analytics platform, plea...
Onex to Announce First Quarter 2024 Results on May 10, 2024
Onex to Announce First Quarter 2024 Results on May 10, 2024 Annual meeting to be held on May 9, 2024 All amounts in U.S. dollars unless otherwise stated TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Onex Corporation (TSX: ONEX) will release its results for the first quarter ended March 31, 2024 on May 10, 2024. A live broadcast of Onex’ webcast to discuss the results will begin at 11:00 a.m. ET on May 10, 2024. A link to the webcast and on-line replay will be available at . As a reminder, Onex’ Annual and Special Meeting of Shareholders will be held virtually on May 9, 2024 at 1...
Natural Health Trends to Report First Quarter 2024 Financial Results o...
Natural Health Trends to Report First Quarter 2024 Financial Results on May 1st HONG KONG, April 24, 2024 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and “quality of life” products under the NHT Global brand, today announced the Company will report its financial results for the first quarter ended March 31, 2024 on Wednesday, May 1, 2024 at 9:00 a.m. Eastern Time. Chris Sharng, Natural Health Trends’ President, and Scott Davidson, Senior Vice President and Chief Financ...
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for C...
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy -Company Aligned with FDA on Demonstration of Non-Clinical Comparability; Allowing for Immediate Use of San Diego Manufacturing Facility- -FDA Feedback Supports Requests for a Pre-BLA Meeting and Subsequent Rolling BLA Submission Following Upcoming Q2 Type-B FDA Meeting- -Company Granted Subsequent Type-B Clinical Meeting with FDA in Second Quarter to Continue to Discuss Pathway to BLA- -Capricor Management to Host Virtual Investor Webcast to Discuss Latest Program Update...
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutti...
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership LOS ANGELES and AMSTERDAM, April 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a trailblazer in AI-driven early cancer diagnostics and therapeutics, and Cyclomics, a leader in ultra-sensitive 4th generation multi-omics molecular biology, proudly announce a significant milestone in their collaboration. RenovaroCube has entered into an amendment to its binding letter of intent to acquire 100% ownership of Cyclomics, further cementing their shared commitment to advancing ...
T2 Biosystems to Report First Quarter 2024 Financial Results and Busin...
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024 LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the first quarter 2024 and business updates after market close on Monday, May 6, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by a...
Digerati Technologies Highlights its Market Reach Across a Wide Range ...
Digerati Technologies Highlights its Market Reach Across a Wide Range of Industries Diverse Client Base Spans California, Texas, and Floridawith an Average Tenure of Eight Years SAN ANTONIO, April 24, 2024 (GLOBE NEWSWIRE) -- Digerati Technologies, Inc. (OTCQB: ) ("Digerati" or the "Company"), a provider of cloud services specializing in UCaaS (Unified Communications as a Service) solutions for the small to medium-sized business (“SMB”) market, is pleased to share its market reach by highlighting customers across a wide range of industries spanning California, Texas, and Florida w...
Cradlepoint 5G-Optimized NetCloud SASE Secures Agile Enterprises
Cradlepoint 5G-Optimized NetCloud SASE Secures Agile Enterprises Zero-trust networks deployable, at scale, in as little as 6 minutes, addresses current industry void for simplified networking and security in dynamic environments BOISE, Idaho, April 24, 2024 (GLOBE NEWSWIRE) -- , part of Ericsson, the global leader in cloud-delivered LTE and 5G wireless network and security solutions, today launched its single vendor Secure Access Service Edge (SASE) solution, NetCloud SASE. Designed to serve agile enterprises, NetCloud SASE integrates cellular-centric SD-WAN and security into a fully un...
Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ Advance...
Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ Advances as Leading Infrastructure Supplier for Colombia’s Top Flower Producers Collaboration with Danziger International is also enhanced as company’s global footprint expands AUSTIN, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- via IBN – Eko2o S.A.S., a pioneering force in agricultural technology and infrastructure, is pleased to announce its continued growth and expansion as a key infrastructure supplier for some of Colombia's largest flower producers. The company is also enhancing its support and sales operations with inter...
AMC Networks to Report First Quarter 2024 Results
AMC Networks to Report First Quarter 2024 Results NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- AMC Networks Inc. (NASDAQ: AMCX) will host a conference call to discuss results for the first quarter 2024 on Friday, May 10, 2024 at 8:30 a.m. Eastern Time. AMC Networks will issue a press release reporting its results before the market opening. The conference call will be webcast live via the company’s website at . To access the conference call via telephone, please pre-register for the call to obtain the dial-in number and a passcode. Pre-registration instructions can be found at under...
HeartSciences Announces Grant of Fundamental Patent by the European Pa...
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG Patent covers use of AI-ECG for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease Southlake, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today ...
Sharecare awarded three-year NCQA Accreditation for Case Management
Sharecare awarded three-year NCQA Accreditation for Case Management Accreditation for its complex case management capabilities complements Sharecare's existing three-year NCQA accreditations for Population Health Program and Wellness and Health Promotion ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: ), the digital health company that helps people manage all their health in one place, today announced it has received a three-year Case Management Accreditation by the National Committee for Quality Assurance (NCQA) for the complex case management capabilities available thro...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.